“…This feature is not conducive to high-resolution imaging, as it necessitates a significant amount of time and repeated injections from diagnosis to treatment . To date, great efforts have been devoted to design and fabricate novel long-circulation MR contrast agents, such as Gd-based contrast agents (Gd 2 O 3 , NaGdF 4 , , Gd-liposomes, , Gd-polymer, and Gd-dendrimer), Fe-based contrast agents (Fe 3 O 4 , Fe 2 O 3 , Fe 5 C 2 , and FeS), and Mn-based contrast agents (MnO, MnO 2 , , MnS, MnCO 3 , and Mn 3 (PO 4 ) 2 ). Despite remarkable advancements, many MRA contrast agents suffer from harsh synthesis conditions, tedious synthesis processes, and the risk of toxicity derived from harmful substances.…”